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Abstract: Late-onset Alzheimer’s disease (LOAD) likely results from combinations of risk factors that
include both genetic predisposition and modifiable lifestyle factors. The E4 allele of apolipoprotein
E (ApoE) is the most significant genetic risk factor for LOAD. A Western-pattern diet (WD) has
been shown to strongly increase the risk of cardiovascular disease and diabetes, conditions which
have been strongly linked to an increased risk for developing AD. Little is known about how the
WD may contribute to, or enhance, the increased risk presented by possession of the ApoE4 allele.
To model this interaction over the course of a lifetime, we exposed male and female homozygote
ApoE4 knock-in mice and wild-type controls to nine months of a high-fat WD or standard chow diet.
At eleven months of age, the mice were tested for glucose tolerance and then for general activity
and spatial learning and memory. Postmortem analysis of liver function and neuroinflammation
in the brain was also assessed. Our results suggest that behavior impairments resulted from the
convergence of interacting metabolic alterations, made worse in a male ApoE4 mice group who
also showed liver dysfunction, leading to a higher level of inflammatory cytokines in the brain.
Interestingly, female ApoE4 mice on a WD revealed impairments in spatial learning and memory
without the observed liver dysfunction or increase in inflammatory markers in the brain. These
results suggest multiple direct and indirect pathways through which ApoE and diet-related factors
interact. The striking sex difference in markers of chronic neuroinflammation in male ApoE4 mice
fed the high-fat WD suggests a specific mechanism of interaction conferring significant enhanced
LOAD risk for humans with the ApoE4 allele, which may differ between sexes. Additionally, our
results suggest researchers exercise caution when designing and interpreting results of experiments
employing a WD, being careful not to assume a WD impacts both sexes by the same mechanisms.
Keywords: late-onset Alzheimer’s disease; Western-pattern diet; memory; liver; neuroinflammation;
diabetes; obesity; ApoE4; modifiable lifestyle factors; C57BL/6NTac mice
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1. Introduction
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A growing body of evidence supports the theory that development of late-onset
Alzheimer’s Disease (LOAD) is the result of interactions between genetic predisposition
and modifiable lifestyle behaviors. Multiple risk factors for Alzheimer’s disease (AD) have
been identified, such as possession of the apolipoprotein E4 (ApoE4) allele, biological sex,
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and dietary patterns contributing to the increasing worldwide incidence of AD through
complex interactions [1]. A better understanding of such interactions would help elucidate
mechanisms by which LOAD develops and may inform novel therapeutic targets and
prevention efforts to better treat this devastating disease.
AD shares common features of other neurodegenerative diseases (NDDs), such as
neuroinflammation, neuronal loss, diminished functional and cognitive outcomes, and
pathological accumulation of proteinacious substances within and surrounding neurons.
In particular, the hallmark of AD is the accumulation of Amyloid-β (Aβ) and tau proteins
(specifically, the pathological form of Aβ-42 and phosphorylated tau (p-tau)). The aggregation of these proteins leads to innate immune responses, such as activation of glial cells
and release of pro-inflammatory cytokines, which results in subsequent neuroinflammation. This cascade of neuroinflammation leads to further neuronal damage and loss [2–4].
These deposits form Aβ plaques in the brain parenchyma surrounding neurons, while
p-tau contributes to tangles formed within neurons, which contribute to the breakdown of
cytoskeletal structure and neurodegeneration [2,5–7].
ApoE is a 34 kDa glycoprotein produced primarily by glial cells and by neurons (under
certain conditions) in the central nervous system (CNS). ApoE plays an important role in
lipid transport and response to excitotoxic injury [8,9]. Further, because ApoE binds to the
Aβ peptide, it has been implicated in Aβ aggregation and clearance in the brain [8,10,11].
The human APOE gene coding for this protein, located on chromosome 19, is polymorphic
and encodes three apoE protein isoforms: E2, E3, and E4. Possession of the E4 allele is
currently thought to be the most significant genetic risk factor related to development of
LOAD. Worldwide, 60% of AD patients possess at least one E4 allele [12]. Possession of the
E4 allele differentially impacts males’ and females’ risk of developing LOAD, with 60% of
AD cases being female [13,14]. In their recent cohort study, the absolute 10-year risk of AD
for those with homozygous possession of the E4 allele differed for women and men and by
age groups, as follows: 60–69 years, 7% and 6%; 70–79 years, 16% and 12%; and 80 years or
older, 24% and 19% [15]. Although the mechanism by which ApoE4 may convey stratified
risk for women is unknown, evidence suggests that it may be due to an interaction between
genotype and the sex hormone estrogen [16–19].
In addition to genetics and sex, lifestyle is also implicated in LOAD [9,19–21]. Among
lifestyle consequences, obesity is recognized as an important modifiable risk factor of LOAD
in humans and has also been shown to both exacerbate and accelerate development of ADrelated pathology in rodent models [22]. Obesity has been linked to metabolic syndrome,
glucose hypometabolism, and insulin sensitivity or resistance [23]. In the CNS, obesity
has been shown to impair the blood–brain barrier (BBB) permeability, activate microglial
response, upregulate inflammatory cytokines’ expression, increase oxidative stress, and
alter the structure and function of hippocampi in rodent models [24–26]. Diet-induced
obesity has been linked to metabolic disorders, maladaptive hormonal signaling, and
pro-inflammatory states, as well as reduced synaptic plasticity and neurogenesis [18,27,28].
In particular, the Western-pattern diet (WD) has been highly correlated to obesity
[22,24,26]. The WD is characterized by a prolonged intake of saturated fats and sugars
and is commonplace in countries adopting a Westernized lifestyle. The translation of the
WD to animal studies is accomplished by dietary formulations with significantly elevated
levels of saturated fats and sucrose and has revealed similar consequences to prolonged
intake of this diet. The WD has been shown to yield increased effects of neuroinflammation
and impair cognition in both humans and rodents [26,29–32] and has been implicated as
a causal pathway to LOAD development, especially as it relates to midlife dietary patterns [33,34]. Murine models have demonstrated WD exposure results in impaired glucose
tolerance [35]. Numerous studies have reported elevated biomarkers of oxidative stress and
neuroinflammation in animals fed a WD [29,30,36,37]. The WD has also been associated
with robust increases in amyloid accumulation and activation of glia [17,22,31,38].
Despite these well-documented findings, the interactions among genetic predisposition, sex, and a WD in the context of LOAD have been understudied. Therefore, this study

Int. J. Mol. Sci. 2022, 23, 3921

3 of 15

aimed to explore the contributions of these risk factors in rodents in which each of these
factors could be controlled. Utilizing transgenic male and female mice homozygous for the
ApoE4 allele versus wild-type (WT) mice, we examined the effects of long-term exposure
to a WD on metabolic variables, measures of neuroinflammation, and behavioral assays.
We hypothesized exposure to a WD would result in metabolic disturbances in all animals
and lead to neuroinflammation and subsequent cognitive impairment, with the greatest
effects being in the ApoE4 groups.
2. Results
2.1. Genotype Does Not Affect Weight Gain
Both male and female WT-fed and ApoE4 control-fed mice gained weight at comparable rates throughout the study (Figure 1). Animals on the WD gained significantly
more weight than their control counterparts (WT control vs. WD: males F(1, 22) = 107.6,
p < 0.0001 and females F(1, 21) = 52.02, p < 0.0001). ApoE4 male and female control-fed
weights did not differ from WT male and female control-fed counterparts. These results
suggest
homozygous possession of the ApoE4 allele alone does not affect
gain in
Int. J. Mol. Sci. 2022, 23, x FOR
PEER REVIEW
4 ofweight
17
young mice fed the WD (Figure 2).

Figure 1. Body weights of WT and ApoE4 mice during the treatment period. Both male and female
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Figure 2. Experimental timeline (GTT = glucose tolerance testing). See Section 4: Methods for details.
Figure 2. Experimental timeline (GTT = glucose tolerance testing). See Section 4: Methods for details.

2.2. WD Alters Glucose Metabolism, Especially in Female Mice
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Figure 3. Glucose tolerance test. Average residual blood glucose levels in the 60 min period post-
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Male and female WT animals exposed to the WD had significantly larger livers than
those on the control diet (Figure 4A), even after correcting for body weight (F(1, 42) = 45.93,
p < 0.0001). Likewise, male and female ApoE4 animals exposed to the WD (Figure 4B)
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8 of 17
marginally increased expression of TNFα ( p= 0.0567) and IL-6 (p = 0.0798) when compared
to control-diet-fed male counterparts.
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2.6. Behavioral Testing Reveals Impairments from WD in Genotype Are Moderated by Sex
In ApoE4 animals, consistently longer latency to escape was observed in WD-fed animals when compared to those on the control diet (Figure 7). This effect was significant
and most pronounced in male ApoE4 WD animals (F(1, 30) = 12.92, p = 0.0011). Both WT and
ApoE4 animals fed a WD demonstrated decreased activity in open-field testing. However,
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2.6. Behavioral Testing Reveals Impairments from WD in Genotype Are Moderated by Sex
In ApoE4 animals, consistently longer latency to escape was observed in WD-fed
animals when compared to those on the control diet (Figure 7). This effect was significant
and most pronounced in male ApoE4 WD animals (F(1, 30) = 12.92, p = 0.0011). Both WT and
ApoE4 animals fed a WD demonstrated decreased activity in open-field testing. However,
this decreased activity could be explained by the increased body mass seen in all WDfed animals, causing impaired ambulation or exertional effects. Though not significant
(p = 0.11), it was observed that ApoE4 animals, particularly ApoE4 females, traveled almost
twice as much in the open field as WT animals. Barnes maze testing revealed increased
latency to escape that approached significance in males (p = 0.0558) but not in female WT
animals subjected to the WD. However, both male and female ApoE4 mice fed the WD
(E,F) showed consistently longer latencies to escape as compared to control-fed ApoE4
mice, with this effect reaching significance and being most pronounced in the male mice
(E) (F(1, 30) = 12.92, p = 0.0011). The increased ambulation in the open field also seen in
this group could explain the shorter latency to escape times; as an animal’s ambulation
increases, one could reason the animal will then find the escape location more quickly. A
flattening of the curve for ApoE4 WD females represents a possible impairment in these
animals in their ability to either learn the task or to recall the location of the fixed escape.
Though, overall, the female ApoE4 animals began with markedly shorter latency to escape
times than all other groups; over the course of the 5-day assay, the addition of the WD
impaired
curve that
Int. J. Mol. Sci. 2022, 23, x FOR PEER
REVIEWthe performance of the ApoE4 females and revealed an acquisition
9 of 17
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cytokine expression were observed as complex interactions. These alterations related to
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several risk factors (ApoE4 carrier status, sex differences, dietary patterns) has become of
particular interest to understanding causal pathways of LOAD [44,45]. There is a dearth
of knowledge on the effects of genetic risk compounded with modifiable lifestyle factors.
Our study aimed to understand the interaction effects of these factors in a mouse model of
LOAD.
We found that alterations in glucose metabolism, liver function, and inflammatory
cytokine expression were observed as complex interactions. These alterations related to
behavioral impairments, with sex and diet moderating the relationship between genotype
and both metabolic and cognitive outcomes. These findings are consistent with an extensive
body of research on the effects of a high-fat diet in mice [37,38,46,47], where male mice show
consistent detrimental effects on neuroinflammation, glucose tolerance, and behavioral
measures [48–50]. In humans, males are at increased risk of developing metabolic syndrome
(MetS), which is associated with obesity [51,52]. ApoE4 possession has also been linked to
increased risk of MetS in a dose-dependent manner as BMI increases [25]. Similarly, rodent
models have demonstrated that possession of ApoE4 increases risk of metabolic syndrome,
possibly by interfering in insulin-sensing pathways [25,53]. In European women under
80, the prevalence of impaired glucose tolerance is higher [54]. We have shown that a WD
alters glucose metabolism in both WT and LOAD animals, especially in females, with the
most profound effect occurring in ApoE4 females. Remarkably, despite experiencing the
most exaggerated response to GTT, ApoE4 females fed the WD showed no effects on liver
weight or GSH levels. Both male and female WT animals fed the WD exhibited significantly
larger livers than their control-fed counterparts. In ApoE4 animals, males fed WD also
yielded significantly larger livers with female ApoE4 animals appearing to be spared from
this effect. Additionally, despite the significant increase in liver weight seen in ApoE4
males fed WD, the ApoE4 males’ liver weight response to the WD was less pronounced
than that of the WT males. While WD exposure resulted in minimally decreased levels
of GSH in the livers of WT animals, the only significant reduction observed was again in
ApoE4 males. This inverse relationship of elevated liver weight and decreased GSH levels
in WD ApoE4 males is particularly interesting, since this group also yielded findings of
elevated markers of neuroinflammation and the poorest performance in the Barnes maze.
Oxidative stress and neuroinflammation have been linked to early biochemical changes
associated with the progression of AD [55] and could explain the severe impairment seen
with Barnes maze.
What is not clear is the explanation for female ApoE4 WD animals demonstrating a
null effect in liver weight, GSH reduction in the liver, and inflammatory cytokine expression
in the brain, yet revealing impairment in cognition as illustrated by the flattened curve in
Barnes performance in this group. Numerous studies in both humans and rodents have
shown sex-dependent effects on LOAD risk and pathology severity [12,35,45]. However,
the literature on humans offers mixed explanations for these observations, with many
supporting the simple notion that longer female life expectancy confers increased agerelated risk, while some epidemiologic reports cite “survival bias” resulting from the
healthiest aged men surviving to older ages and driving down AD occurrence in males [56].
Some studies have suggested the ApoE4 genotype may have a stronger relationship with
development of AD in women versus men [45,56,57], perhaps due to hormone effects.
Age and sex interact with ApoE4 and obesity to combine for increased detrimental
effects on metabolism and cognition [58]. Although the underlying explanation for these
observations remains to be elucidated, several explanations have been offered, such as
differential impacts of aging, sex differences in lean muscle mass, adipocyte distribution,
influence of the estrous cycle and menopause, and invoked susceptibility to free-fatty
acid-induced peripheral insulin resistance [54]. Human males and females show distinct dimorphism and substantial variability in adipocyte distribution that may be exclusive to our
species [53]. Adipocyte size is important in determining its function and metabolic activity,
regardless of obesity level, and is closely correlated to insulin resistance, dyslipidemia,
and triglyceride synthesis [54]. The location of adipose tissue can be either subcutaneous
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(SAT) or visceral (VAT), and each type relates differently to development of Mets across an
aging continuum. VAT is closely correlated to metabolic disturbances and cardiovascular
risk [59,60]. Males tend to develop more VAT, which remains stable across a lifetime but
responds better to overall weight reduction, whereas females tend to develop more SAT,
which has been reported to show protective effects [61,62]. In one study, premenopausal
women were observed to accumulate a substantial amount of total body fat before increases
in VAT were noted [63]. Postmenopausal women accumulate more VAT, which increases in
size due to estrogen-depletion-induced hyperplasia [63]. In one recent study, female ApoE4
mice subjected to ovarian failure revealed cognitive impairment and extensive deficits in
synaptic-plasticity-related signaling [58].
Taken together, these findings may suggest a mechanism where males with possession
of both ApoE4 alleles may be more susceptible to the deleterious metabolic effects of
prolonged exposure to a WD. We suggest that in males homozygous for ApoE4, a WD leads
to metabolic dysfunction that results in an increase in liver weight, impaired liver function,
and impairment in glucose metabolism. Liver dysfunction and altered glucose metabolism
yield an increase in pro-inflammatory cytokine expression in the brain, thereby contributing
to oxidative stress and neurodegeneration and leading to cognitive impairment. In female
ApoE4 mice chronically exposed to a WD, no such metabolic changes were observed except
for the exaggerated response to glucose tolerance. Although ApoE4 females did arrive
at the similar endpoint of impaired learning and memory as demonstrated in behavioral
testing on the Barnes maze, there is no clear causal pathway that emerged from our
findings. Therefore, we must be careful not to assume these effects were simply due to an
altered metabolic response as indicated by the GTT results, as there were no changes in
inflammatory cytokine expression in the brains of these animals. Further investigation is
needed to expose a possible alternative explanation as to the mechanism by which ApoE4
females fed a WD become cognitively impaired over time.
It is possible, even likely, that adipocyte distribution and size differences between
the sexes, combined with hormonal signaling effects of substances such as estrogen and
leptin (which are stored in these adipocytes), may play a crucial role in understanding how
the moderating effects of sex and diet on ApoE4 carry status and risk of LOAD. Future
research should focus on investigating potential sex-specific factors, such as estrogen, that
may moderate the relationship between the WD and development of LOAD in females
carrying both E4 alleles. One important point to consider when seeking to elucidate these
mechanisms is the age of animals, particularly as they relate to the estrous cycle. Extensive
literature reviews revealed a body of research focusing primarily on either younger or
older models. Our study was conducted using a one-year time point (after 9 months on
diet), which equates to a mid-life paradigm in C57BL/6J mice. After 6 months of age, mice
mature at a rate 25 times that of humans. Therefore, our 12-month timepoint correlates
to humans 38–47 years old [64,65]. It is likely that possession of ApoE4 affects females
differentially across an aging continuum, and future studies should seek to probe into WD
effects in aged mice at later timepoints.
It is also interesting to consider what our findings say about using a WD manipulation to invoke metabolic syndrome in mice. Despite resulting in obesity in all groups of
treated mice, we observed a clear dissociation between the liver vs. glucose regulation
consequences in our mice. This suggests that investigators should be cautious in assuming
a WD produces a unitary metabolic syndrome-like pattern of effects in mouse models.
Importantly, studies have shown male mice are more vulnerable than female mice to
deleterious effects of a WD on weight, metabolic alterations, and deficits of learning, and
hippocampal synaptic plasticity [58,66]. Further research will need to elucidate the specific
potential divergent casual pathways, particularly the sex differences, on human ApoE4 risk
in relation to diet. Our research raises the probability that precision medicine approaches
may be of great benefit to targeting the prevention and treatment of AD, especially as sex
differences and timing of intervention may differ greatly for individuals homozygous for
ApoE4.
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4. Limitations
A limitation of our study was the use of whole brain homogenate to assess for markers of neuroinflammation. Our study did not utilize sectioning or immunohistochemistry/staining techniques to look for accumulation of AD biomarkers (Aβ, p-tau), nor did
we look at markers of glial/immune activation, neurodegeneration, necrosis, or autophagy.
Additionally, we did not examine the VAT pads postmortem in our mice, which would have
been helpful to better understand the relationship of overall weight gain versus the increase
in VAT between the sexes. Future studies should consider measuring these biomarkers
and tissues and examine specific regions, such as the hippocampi and medial temporal
lobes, frontal lobe, entorhinal cortex, and ventromedial prefrontal cortex (vmPFC), areas
shown to be involved in learning and memory, accumulate protein aggregates, and show
neurodegeneration, and are thought to be functionally connected [67–69]. Since our study
looked at “middle-aged” mice, future studies should seek to replicate our findings and
add additional aging timepoints (perhaps at additional 3-month intervals) to follow the
progression of continued exposure to a WD to potentially observe a difference in female
ApoE4 mice at later points as estrogen levels decline.
5. Materials and Methods
5.1. Animals
Transgenic mice expressing human ApoE4 + /+ (C57BL/6NTac-Apoe < tm4207.1,
APOE*R130, *R176) and wild-type (WT) controls (C57BL/6NTac) were purchased from
Taconic Biosciences, Inc. (Rensselaer, NY). Mice were aged eight weeks, then were maintained on either normal chow (ENVIGO TD2014, 14% protein, Indianapolis, IN) or WD
(ENVIGO TD81337, adjusted-calorie diet with 42% kcal from fat) with water available ad
libitum. All animals were housed in a temperature-controlled room (22 ± 2 ◦ C and 40–60%
humidity) on a standard 12 h light cycle. At 46 weeks of age, following metabolic and
behavioral testing, mice were deeply anesthetized with I.P. administration of ketamine
(80 mg/kg) and xylazine (10 mg/kg) and euthanized via terminal cardiac puncture. Animal blood, brain, and liver tissue was collected for further analysis. All animal procedures
were performed in accordance with NIH’s Guide for the Care and Use of Laboratory Animals
and University of Rhode Island’ Animal Care and Use Committee’s (IACUC) guidelines.
5.2. Glucose Tolerance Testing (GTT)
At 44 weeks of age, one week prior to behavioral testing, animals underwent oral
glucose tolerance testing (GTT). After a six-hour fast, baseline blood glucose was measured
vial lateral tail vein puncture using an AlphaTrak 2 glucose testing system (Zoetis, Parsippany, NJ, USA). Animals were dosed via oral gavage, with a 2 g/kg dose of anhydrous
D(+) glucose (Sigma Aldrich, St. Louis, MO, USA) mixed with sterile water and given a
1 mL/kg bolus, according to weight. Blood glucose levels were measured post-gavage at
15, 30, and 60 min, respectively.
5.3. Behavioral Assays
5.3.1. Open Field
The Open-Field test was conducted to assess general locomotor activity, exploratory
behavior, and anxiety-like behavior at 45 weeks of age. The apparatus (Stoelting Co.,
Wood Dale, IL, USA) comprised a gray, non-reflective, powder-coated metal base (40 cm2 )
surrounded by gray, opaque walls (35 cm high). Animals were placed in the center of the
open field and allowed to explore the area for 10 min, during which time the number of
animal rears were manually scored by the experimenter while general locomotion activity
(i.e., speed and distance travelled) was automatically recorded by AnyMazeTM behavioral
tracking software (version 6.1, Stoelting Co., Wood Dale, IL, USA). Rearing was defined
as an animal lifting off from its front paws and placing all its weight on its hind paws,
including when assisted by a wall.
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5.3.2. Barnes Maze
The Barnes maze was conducted to assess spatial learning and memory. The maze
(Stoelting, Co., Wood Dale, IL, USA) was made from a circular, gray, non-reflective, powdercoated metal base platform with a diameter of 91 cm. Twenty holes, each with a diameter
of 5 cm, surrounded the perimeter of the maze at 2.5 cm from the edge. One hole was
designated as the escape location and a 7.5 × 15 × 5 cm goal box was situated beneath the
hole to allow the animal a point of egress and seclusion. Testing occurred each morning
at the same time of day over five days. Prior to each trial, animals were acclimated to the
testing room for 15 min. During testing, animals were placed inside a 10 × 10 × 20 cm
plastic, semi-opaque acclimation container in the center of the maze for 20 s. Then, the
container was removed, and the animal was allowed to explore the maze for a maximum of
300 s, or until they successfully found the escape hole. Animals remained (or were placed
inside) the escape box with the hole covered for one minute to reinforce the location of
escape. After one minute, animals were returned to their home cage. Following completion
of each trial, the maze and escape box were thoroughly cleaned with a solution of 70%
ethanol to mask olfactory cues from previous trials.
The Barnes maze and open-field apparatus were placed on top of a platform, 80 cm
above the ground, and made level. The platform was situated in the middle of a dedicated
room, as far away from the investigator as possible, under a fixed ceiling lighting apparatus.
Extra-maze visual cues were fixed at eye-level for the animals and remained constant
for every cohort. All activity was recorded using a Logitech C270 web camera mounted
1.5 m above the maze, and AnyMazeTM behavioral tracking software was used for data
collection.
5.4. Enzyme-Linked Immunosorbent Assay (ELISA)
Levels of inflammatory cytokines tumor necrosis factor α (TNFα), interleukin (IL)-6,
and IL-1β were measured in whole-brain homogenate using Enzyme-Linked Immunosorbent Assay (ELISA) from Biolegend (San Diego, CA, USA); mouse IL-1β cat.
#432604, Mouse TNFα cat. #430904, Mouse IL-6 cat. #431304) in 3–5 mice drawn
randomly from each test group. The protocol provided by the manufacturer was followed,
without modifications. At the conclusion of the assay, absorbance was detected at 570 nm
and 450 nm using Synergy HTX multi-mode reader (Biotek Instruments, Winooski, VT,
USA).
5.5. GSH ELISA
The levels of reduced glutathione (GSH) were assessed in liver homogenate using a
Glutathione Colorimetric Detection Kit (Invitrogen), according to manufacturer’s instructions. Briefly, whole liver was sectioned and homogenized by sonication (Branson SX150
Sonifier® , Branson Ultrasonics, Danbury, CT, USA) in phosphate-buffered saline (PBS) with
1× protease inhibitors. Samples were further diluted according to kit instructions, added to
a 96-well microplate, then incubated with reaction mixture for 20 min at room temperature.
Following incubation, samples were read for absorbance at 405 nm using Synergy HTX
multi-mode reader (Biotex Instruments, Winooski, VT, USA).
5.6. Statistical Analysis
All tests were performed in GraphPad Prism, version 9.1.0 (GraphPad, CA). Data
are represented as mean +/− standard error (SEM). ELISA analysis was conducted using
analysis of variance (ANOVA) with Bonferroni’s correction for multiple comparisons with
group N = 3–5. Behavioral measures assessed for differences between groups using two-way
and mixed-model ANOVA with either Tukey’s (open field) or Bonferroni’s (weights, GTT,
Barnes maze, liver weights) multiple comparisons tests for post hoc discovery. Statistical
significance was set at p < 0.05, and group N is listed in Figure 2 for the behavioral testing.
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